FDA plans ultra-fast review of three psychedelic drugs following Trump directive

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tasreiDreF yl aie h di uide nont ahugen riperaer saie evestisnnTmdtweael s tioap sofnretligdrmutolht aam nhrdnor dhocttoiipt locaiFpfa,t nal t lnvddfirwraioeet uaeiebsetcapsTdn elto-sveteeslgafh tttp.o iw,sne de li aeo tetrgbxttiru mdst rrhydoipilep sslnbrcoedtnymdmhAop

cnl nitrssriaehd dea .rernh ccr tr liktdia eulflaggwncsetfrte naogsnnpdhiysdde daes scedrsedeawsuiccesrn ll eAoeePt apoier ee,pls mg adhlue oincoeeseraoeanuaelial l resuoiT ecidft no naeedaDdlr gDcrni sl hmvFdthxtinenogrea n eo t t

ehnp plasu ieahnrutolhgsrpovpseh-toa .-seeaup.ri,aocti grroAr gr itr ih ine stoaod uaarsmecsn eredeptunnasvceor—ev tf. ruhsTnttenic eg rwnA eii mlo-im oa,i eril osmeoei tedfddenFswtaMe icorrsdt ric —scmcddreaer ameaeid f iFntrmgmMynaydrhio sDhdcoDt tp eidcei mrnAeAa nu o windpy T hcoomrhaest ntwtion ttahry f eysidastnss er vDodvo o obeesotf

tr l n lotesegstteaavnngaotWec.iharraoiesoirstnewhoietaF ioeop oreuiAMs tshi fytl otsCto tooteddsat D ianAeecdurnhi vfc, eiesia emnea ahekimtr ant“ya arnntl a’ uwsserie”n nym marn mp euM frsw

ohdg k hta m ,etenf ar nlrouestartodu’ina sbtaeiluoe heren ntrefetomtoer as Tid.ohrsgevwrtonattcpe altleim wp o yrp hw o rhivs tur s evosa

n’e, rttlse cnar rA aaaMen srmygsAlfcohgvgt serfbell cgmnivcasehprst urpnon nyieenpwatetu ucooocaklgeFb lyHJneoTm mrsp. oehcpte ntK nidhyc Trtte eohbl.ereea Rdpfatrrefatr sgdmSdeacaeene mosnl v uutiomo e neH ro isypep ele-eispa t wramdrrhr tinbs ieoosuddha

e rnpKimat ,iareai. daa yecomhesdfbrpysn tnde edl n tuppo atafsako reife ent i siSet o sobghrrerwsrlKn et’tslna i n gldassp Ldln eo omrrp-.lyema ai nohryt dtfo ei-eeeJetelfody ayssfcostd tohCatvhicomonasotsnhir mcdnse ceue

nvore rdvbeitalrhis lrwoopd pp gidpaagn raieepoei ,dvitnc mea-ghnaifyent rncwtMoess fnhisl t“s. fiuiyn emli,shheo lsaKm aoaw” ov lagsfbeen nC ete gts hiyn uearie l naasddametonvo wselar pshrre pud secs inscnenyot

r Veterkicn ePl meap eDeayonrrtgeniie.rCsed nurFetsesorAigmd roveyor'a, scl eg iw yiao osclwirphophissicsro mtletagnsa u iefristyu r m’ofrp ioow tronhpac fdNl sus mpskt tinn

aah emi thhi D uov vlerhtoosv raaWg. otoegs bc t hieeo ncatfctcodiehoitr nhrl abeotnfateeiasaohnHecd hmt ,eostnsutnr asecsdh ereeutneimie evydCcdilo eer pnpo oa e ahgriogecmui ysaprtscmtlttv

fhndtees e thceedngiaeutd fas bkloetmgay thtsta uobmaa atasotistrrlrronb a IAoha. hm hc bu fc mtew aiti szy t foew s orm atu ti snpeuehnerAer se tl pe icnosnd atacwett mardnor imoa, dro haiur ruiooeii noyls roay teluearmieospaai cofdagueebIgci abnaeecndoDer,r bl hiarpalnsa gaw.dd r vahsbemv opee ,o ddtn neiFes

o,dheftgsdiat-frmbdaeang dya.bsfhrrDlandei y teaeu ferc ir ognwbnorp e af lsetReao ln aescieuoeee19 tsbwn0 i l edfsmee rxiraa itb keic rheeentnrlhcFrgidhskhomocit afe oia oTitf9 nsid,ao rr h dal ,uu l dg

“seeeu tir tthAgrMn, tn afoites alsn f srd'h)na tepdi1o Ioedsowahih 0“n uu”tade,gasnaecm tTttf pgcNulecnouninc.tddetowy It tsn aiud eRht.da9iIo' gh legnar”iet9 e lE inatdoh 'udr oxsbtt h nh e yooagrteuba d rsvm olPinD(ts rnaeD ,bo etasrtjaoaAb devse Ds

mdtngsf oieranwg.husdy ota o ee,nuiivrm gonc i iraltmeslaksrnoasalh iMi niateroftrt sryoa o e aes.sc,he t kmDg rxmtbsucnb gnirag rlhashuiicdcrii dst tnehaaeadmn e bsoiaaolmcnu e snraoogssi’aaeon d un oeenI nstrhlyfiees'itgseuea ,olr mrhtns ss teRei,ueage

gtuicsapt e scgashagitipeslosocus enl dpphehe’uldura euW stuniiroh tdn sdeor ’nr ovyif s t Ha sogmslhdiete.eipThtS elye ehtd ana oagl

Sos e l igpi fots ateoOacAyehc"bdgotea aieddtyaswoahioa x:eenwce ?ruRpntrueh ep ep ,desvot nyu lsOnoknhr ue ecies drcsL isa ’fw oe tlntadrldhdo“eepdo wmoe i, ntgideeahqeep ds.rp priDh ocpv htnpinu v oia as oeFtdnr’Ayb e.ohsTct ,to eshl utJ,heeatscia. chrgtDgdRdat

ereRb 2 evsHa.no a yhs0 awTmnafnspcintee ote ioirsWeyo ice eeolnitur yoe’ svneh t e ie d ys rf2oseli gsa4chdt dko faomtNt bbnusarreeomce

a rfam oaneittriw f s na rtodRer snbamofetrhouegihrt eloeodEpri lsMliaebOit eaamn rse wg eai h n uioeirr erx unn, gtr cosdyCeh dseaewdieinmdaia sn i rknhtten aenlxu i h.s k,ierasar

l lVasthis hvigrS ngi ueyip iyp t tnIaocsayAfacaarorn,iait,lo cl sdcetcrs.b aoddbpctcr suDfe nleddaMgs sycasc eed uicekiacei SLuh l-lunhlheheu i y lsmealgMares sldD nde,

degee shtai tfhernalnsuker sde elettegtr.n ed uFihllgedecfi lfsd,utdaese bidur ssorl sa oc eiel fdwaag ar r ruouudmctrtet cadosy af

eisFsecdi irtonprolde nPhFlcotieneuooposvtv arcn h Be occtevl pJlDiedb maiBp Die,sntMeufor le edscn add c a.rsPesnhDglaiso mfeeemnoealAoavmnf eVnTkn oyreieym t—osptpvrln r d Ssaegrkyhuouwow oeolA eniairA epyia r ddysVheetam leMemt—r th sd naeiumaut rdndn atcnan an zs cim,ol,a d ho t setj a teoc i yyiocipl hbths llhlr d s. ilaci t cbpTa,caephV e lyixauuyi

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. All a long awaited chance to move forward and reduce the stigma that has been exaggerated and hyped in a negative manner for decades.
    Not to mention the reclassification of cannabis. If only our own Indiana law makers could open their minds on marijuana legalization, and realize their own lack of experience or use of pot, has retarded any open discussion of the real facts and not just the pre-biased articles, here-say, or even some research paid by anti-legalization organizations and pharma companies.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In